Associations between subclinical thyroid disease and metabolic syndrome

Endocrine Journal

Volumn 59, Issue 10, 2012, Pages 911-917

  Wang, Chih Yuan ^a   Chang, Tien Chun ^a   Chen, Ming Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Biochemical markers; Metabolic syndrome; Subclinical thyroid disease; Thyrotropin

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; EUTHYROIDISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC SYNDROME X; PREVALENCE; PULSE RATE; RISK FACTOR; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL THYROID DISEASE; SYSTOLIC BLOOD PRESSURE; THYROID DISEASE; THYROID FUNCTION TEST; WAIST CIRCUMFERENCE;

ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTHYROIDISM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; TAIWAN; THYROID DISEASES; THYROTROPIN; TRIGLYCERIDES;

EID: 84869221096     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0076     Document Type: Article

References (15)

1. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ (2004) Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291: 228-238.
2. Jones DD, May KE, Geraci SA (2010) Subclinical thyroid diseases. Am J Med 123: 502-504.
3. Serafidis PA, Nilsson PM (2006) The metabolic syndrome: a glance at its history. J Hypertens 24: 621-626.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
6. Tan CE, Ma S, Wai D, Chew SK, Tai ES (2004) Can we apply the National Cholesterol education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care 27: 1182-1186.
7. Lai CC, Tang SH, Pei D, Wang CY, Chen YL, Wu CZ, Hsiao FC, Chen HS, Wang JY (2011) The prevalence of subclinical thyroid dysfunction and its association with metabolic syndrorme in Taiwanese elderly. Int J Gerontol 5: 25-29.
8. Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, Liu H, Li C, Xue H, Li N, Yu J, Shi L, Bai X, Hou X, Zhu L, Lu L, Wang S, Xing Q, Teng X, Teng W, Shan Z (2011) The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J 58(1): 23-30.
9. Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA (2010) TSH and free thyroxine concentrations are associated with differeing metabolic markers in euthyroid subjects. Eur J Endocrinol 163(2): 273-278.
10. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L, Jørgensen T (2005) Small difference in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90(7): 4019-4024.
11. Biondi B, Cooper DS (2008) The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29(1): 76-131.
12. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, Wilson PW, Benjamin EJ, D'Agostino RB (1994) Low serum thyrotropin as a risk factor for atrial fibrillation in older patients. N Engl J Med 331(1): 1249-1252.
13. Parle JV, Maisonneuve P, sheppard MC, Boyle P, Franklyn JA (2001) Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358: 861-865.
14. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B (2003) Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? Atherosclerosis 166(2): 379-386
15. Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU (2007) The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomized, crossover trial. J Clin Endocrinol Metab 92: 1715-1723